Delivery Order SPE2DB22D3016-SPE2DB24FABR8
- Not listed
- This federal contract award is for the delivery of NITROFURANTOIN MONO-MCR 100 MG UD 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,397.64 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 12, 2024. The contract was not set aside...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $26,116.35 for the supply of 4,562,252 units of NITROFURANTOIN MONO-MCR 100 MG. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 21, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $30,697.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,182,939 units of Nitrofurantoin Mono-MCR 100 mg medication to support federal healthcare programs. The award is a firm-fixed-price delivery order with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, which is a generic pharmaceutical product. The delivery order has a ceiling value of $3,674.38 and a completion date of January 24, 2025. This contract award is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,106.37, is for the delivery of 4567670792 NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 25, 2025. It is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,563,471,607 units of Nitrofurantoin Mono-MCR 100 mg, a pharmaceutical product, with a ceiling value of $24,412.43 and a completion date of January 30, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,962.11 firm fixed-price delivery order is for the supply of 4,566,995,841 units of NITROFURANTOIN MONO-MCR 100 MG 1000S, a generic pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,601.77, is for the provision of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This federal contract award, valued at $12,630.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $5,101.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S, a pharmaceutical product, with a completion date of May 14, 2024. The contract type is Delivery Order with a Firm Fixed Price pricing structure. There was no set-aside designation associated with this award....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FABR8Delivery Order
This federal contract award is for the delivery of NITROFURANTOIN MONO-MCR 100 MG 100S medication to the Defense Logistics Agency (DLA). The contract, valued at $5,276.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on October 27, 2022 with an ultimate completion date of October 30, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 10/27/23 |